CPC A61K 31/445 (2013.01) | 6 Claims |
1. A method for treatment of SARS-COV-1, SARS-CoV-2 (Covid-19) and MERS-CoV, and variants within each, in a mammalian subject in need thereof, comprising administering to the subject an effective amount of the following benzimidazole compounds:
wherein, X can be —CH2— or C═O, and R can be —OCH3 or —NHCH3, or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.
|